DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pip... DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 1.20068610635 | 5.83 | 6.15 | 5.52 | 44395 | 5.87544654 | CS |
4 | 0.61 | 11.5311909263 | 5.29 | 6.39 | 4.88 | 80930 | 5.68194414 | CS |
12 | 1.65 | 38.8235294118 | 4.25 | 6.41 | 3.92 | 113414 | 5.12392678 | CS |
26 | 2.6 | 78.7878787879 | 3.3 | 6.41 | 3.25 | 76833 | 4.79151088 | CS |
52 | 2.99 | 102.749140893 | 2.91 | 6.41 | 2.14 | 64185 | 4.07690647 | CS |
156 | 3.21 | 119.330855019 | 2.69 | 6.41 | 1.12 | 72234 | 2.86105268 | CS |
260 | 1.63 | 38.1733021077 | 4.27 | 10.88 | 1.12 | 102068 | 4.42060261 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales